Fundz

Exosome Diagnostics, Inc. reported raising $15.5 Million in an initial SEC Form D filing

PRIVATESep 15, 2015

Amount Raised

$15.5 Million

$15.5 Million sold, per SEC Form D (first sale Sep 15, 2015)

Round Type

Venture

WalthamBiotechnologyHealthcareHealth CareHealth Diagnostics

Quick answer

Exosome Diagnostics raised $15.5 Million in a funding round, dated September 15, 2015. Exosome Diagnostics is based in Waltham, Massachusetts, United States.

How much did Exosome Diagnostics raise?
Exosome Diagnostics raised $15.5 Million in a funding round on September 15, 2015.
What does Exosome Diagnostics do?
Exosome Diagnostics, Inc. specializes in non-invasive testing to help guide patient treatment decisions in oncology and other areas.
Where is Exosome Diagnostics based and how big is it?
Exosome Diagnostics is based in Waltham, Massachusetts, United States. Fundz records about 88 employees.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Diagnostics around the same time

Companies in the same sectors as Exosome Diagnostics that raised within 45 days of this round, from Fundz verified event records.

  • Insight Molecular Diagnostics Inc. raised $8.3M on October 15, 2015.
  • BIODESIX INC raised $8.6M on October 8, 2015.
  • CytoDyn raised $2.7M (Seed) on October 5, 2015.
  • Deciphera Pharmaceuticals raised $22M on September 29, 2015.
  • Corvus Pharmaceuticals, Inc. raised $75M on September 25, 2015.
  • Eximis Surgical raised $270K (Seed) on September 23, 2015.

Who to call at Exosome Diagnostics, and when

A new round usually means Exosome Diagnostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Exosome Diagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Exosome Diagnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Exosome Diagnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Exosome Diagnostics

Location

Waltham, Massachusetts, United States

About

Exosome Diagnostics, Inc. specializes in non-invasive testing to help guide patient treatment decisions in oncology and other areas. Their flagship product is the ExoDx Prostate test, which provides actionable information regarding prostate cancer. The company is known for its advances in exosome-based diagnostics. Further details on their operations are not specified.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Exosome Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Exosome Diagnostics's next move

See what Strategic adds

Exosome Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.